LEWIS-HALL FREDA C 1437909 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-24 | 2023-05-24 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 4648.0 | 43.97 | 0.74 | 0.0 | Direct | Common Stock | SPRINGWORKS THERAPEUTICS, INC. | code A | 10572.0 | 62.52 (SWTX) |
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 3599.0 | 18.28 | 0.2 | 0.0 | Direct | Common Stock | EXACT SCIENCES CORP | code A | 19688.0 | 180.39 (EXAS) |
| 2023-09-26 | 2023-09-22 | 3 | Lewis Hall Freda C | DIRECTOR | holding | 2003324.0 | 0 | 0.0 | See Footnotes F1 | Common Stock | CONDUIT PHARMACEUTICALS INC. | NA | 0.0 (CDT) | |||
| 2023-09-26 | 2023-09-22 | 3 | Lewis Hall Freda C | DIRECTOR | holding | 516987.0 | 0 | 0.0 | See Footnotes F3 | Shares | CONDUIT PHARMACEUTICALS INC. | NA | 0.0 (CDT) | |||
| 2024-03-28 | 2024-03-26 | 2024-03-26 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 35219.0 | 14.59 | 7.95 | 0.0 | Direct | Common Stock | PYXIS ONCOLOGY, INC. | code A | 241405.0 | 44.32 (PYXS) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-24 | 2023-05-24 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 13774.0 | 100.0 | 2.2 | 32.27 | Direct | Stock Option (Right To Buy) | SPRINGWORKS THERAPEUTICS, INC. | code A | 13774.0 | 62.52 (SWTX) |
| 2023-12-14 | 2023-12-01 | 2023-12-01 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 65000.0 | 100.0 | 8.93 | 5.51 | Direct | Stock Option (Right To Buy) | CONDUIT PHARMACEUTICALS INC. | code A | 65000.0 | 72.81 (CDT) |
| 2024-04-24 | 2024-04-22 | 2024-04-22 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 400664.0 | 100.0 | 54.27 | 3.12 | Intelmed Llc | Warrant (Right To Buy) | CONDUIT PHARMACEUTICALS INC. | code A | 400664.0 | 73.83 (CDT) |
| 2024-04-24 | 2024-04-22 | 2024-04-22 | 4 | Lewis Hall Freda C | DIRECTOR | acq | 103397.0 | 100.0 | 14.0 | 3.12 | Emerson Hall | Warrant (Right To Buy) | CONDUIT PHARMACEUTICALS INC. | code A | 103397.0 | 73.83 (CDT) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)